Gonococcal susceptibility to antimicrobials in Baltimore, 1988-1994: What was the impact of ciprofloxacin as first-line therapy for gonorrhea?

Sexually Transmitted Diseases

Volumn 23, Issue 3, 1996, Pages 213-218

  Zenilman, Jonathan M ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBODY RESPONSE; ARTICLE; BACTERIUM ISOLATION; GONORRHEA; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; ORAL DRUG ADMINISTRATION; PROPHYLAXIS;

EID: 0029934633     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199605000-00009     Document Type: Article

References (23)

1. Centers for Disease Control. Sexually transmitted diseases treatment guidelines. MMWR 1989; 38(S-8):9-24.
2. Echols RM, Heyd A, O'Keeffe BJ, Schacht P. Single-dose ciprofloxacin for the treatment of uncomplicated gonorrhea: a worldwide summary. Sex Trans Dis 1994; 21:345-352.
3. Moran JS, Zenilman JM. Therapy for gonococcal infections: options in 1989. Rev Infect Dis 1990; 12(Suppl 6):S633-S644.
4. Zenilman JM, Bonner M, Sharp K, Rabb JA, Alexander ER, and the Disease Intervention Staff of the Dade County Health Department. Penicillinase-producing Neisseria gonorrhoeae in Miami: role of core-group transmitters and the impact of illicit antibiotics. Sex Transm Dis 1988; 15:45-50.
5. Boslego JW, Tramont EC, Takafuji ET, et al. Effect of spectinomycin use on the prevalence of spectinomycin-resistant and of penicillinase-producing Neisseria gonorrhoeae. N Engl J Med 1987; 317:272-278.
6. Centers for Disease Control. Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones: Ohio and Hawaii, 1992-1994. MMWR 1994; 43:325-327.
7. Knapp JS, Washington JA, Doyle LJ, Neal SW, Parekh MC, Rice RJ. Persistence of Neisseria gonorrhoeae strains with decreased susceptibilities to ciprofloxacin and ofloxacin in Cleveland, Ohio, from 1992 through 1993. Antimicrob Agents Chemother 1994; 38(9):2194-2196.
8. Knapp JS, Ohye R, Neal SW, Perekh MC, Higa H, Rice RJ. Emerging in vitro resistance to quinolones in penicillinase-producing Neisseria gonorrhoeae strains in Hawaii. Antimicrob Agents Chemother 1994; 38:2200-2203.
9. Gorwitz R, Nakashima A, Moran J. Sentinel surveillance for antimicrobial resistance in Neisseria gonorrhoeae: United States, 1988-1991. MMWR 1993; 42(Suppl SS-3):29-39.
10. Schwarcz SK, Zenilman JM, Knapp JS, et al. National surveillance of antimicrobial resistance in Neisseria gonorrheae. JAMA 1990; 264:1413-1417.
11. Reichart CA, Neumann T, Foreman P, Zenilman JM, Hook EW. Temporal trends in gonococcal antibiotic resistance in Baltimore. Sex Transm Dis 1992; 19:213-218.
12. Jones RN, Gavan TL, Thornsberry C, et al. Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline. J Clin Microbiol 1989; 27:2759-2766.
13. National Committee for Clinical Laboratory Standards. Approved standard M7-A3: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villanova, PA: National Committee tor Clinical Laboratory Standards, 1993.
14. Hutchinson CM, Rompalo AM, Reichart CA, et al. Characterisitcs of patients with syphilis attending Baltimore STD clinics. Arch Intern Med 1991; 151:511-516.
15. Davis H, McGoodwin E, Reed TG. Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989; 111:1041-1044.
16. Peterman TA, Zaidi AA, Lieb S, Wroten JE. Incubating syphilis in patients treated for gonorrhea: a comparison of treatment regimens. J Infect Dis 1994; 170:689-692.
17. Whittington WL, Knapp JS. Trends in antimicrobial resistance in Neisseria gonorrhoeae in the United States. Sex Transm Dis 1988; 15;202-210.
18. Zenilman JM, Knapp JS, Whittington WL, et al. Characterization of penicillinase-producing Neisseria gonorrhoeae isolates in Miami, Florida 1983-1986. Sex Transm Dis 1988; 15:158-163.
19. Morse SA, Lysko PG. Gonococcal strains from homosexual men have outer membranes with reduced permeability to hydrophobic molecules. Infect Immun 1982; 37:432-438.
20. Faruki H, Sparling PF. Genetics of resistance in a non-lactamase producing gonococcus with relatively high-level penicillin resistance. Antimicrob Agents Chemother 1986; 30:856-860.
21. Morse SA, Johnson SR, Biddle JW, Roberts MC. High-level tetracycline resistance in Neisseria gonorrhoeae is result of the acquisition of the streptococccal tetM determinant. Antimicob Agents Chemother 1986; 30:664-670.
22. Wright RA, Judson FN. Relative and seasonal incidence of the sexually transmitted diseases: a 2-year statistical review. Br J Vener Dis 1978; 54:433-440.
23. Jaffe HW, Zaidi AA, Thornsberry C, Reynolds GH. Trends and seasonality of antibiotic resistance in Neisseria gonorrhoeae. J Infect Dis 1977; 136:684-688.